XML 17 R2.htm IDEA: XBRL DOCUMENT
v3.25.3

Offerings - Offering: 1 | Nov. 12, 2025 USD ($)
--- | ---
Offering: |
Fee Previously Paid | false
Rule 0-11 | true
Transaction Valuation | $ 2,101,825,233.00
Fee Rate | 0.01381%
Amount of Registration Fee | $ 290,262.06
Offering Note | (i) Title of each class of securities to which transaction applies: Ordinary shares, nominal value $0.01 per share, of Avadel Pharmaceuticals plc. (ii) Aggregate number of securities to which transaction applies: As of the close of business on November 7, 2026, the maximum number of ordinary shares to which this transaction applies is estimated to be 110,456,049, which consists of (a) 97,817,589 outstanding ordinary shares (including restricted stock awards); (b) 12,419,785 ordinary shares subject to outstanding stock options to purchase ordinary shares; (c) 218,675 ordinary shares subject to outstanding time-based restricted stock unit awards; and (d) 44,029 shares of ordinary shares estimated to be issuable pursuant to Avadel's Employe Stock Purchase Plan (the "ESPP"). (iii) Per unit price of other underlying value of transaction computed pursuant to Rule 0-11 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"): Estimated solely for the purpose of calculating the filing fee, as of November 6, 2025, the underlying value of the transaction was calculated based on the sum of: (a) the product of 97,817,589 outstanding ordinary shares (including restricted stock awards) and the per share transaction consideration of $20.00; (b) the product of 12,419,785 ordinary shares subject to outstanding stock options to purchase ordinary shares and $11.29 (which is the difference between the per share transaction consideration of $20.00 and the weighted average exercise price of $8.71); (c) the product of 218,675 ordinary shares subject to outstanding restricted stock unit awards and the per share transaction consideration of $20.00; and (d) the product of 44,029 shares of ordinary shares estimated to be issuable pursuant to the ESPP and the per share transaction consideration of $20. In accordance with Section 14(g) of the Exchange Act, the filing fee was determined by multiplying the sum calculated in the preceding sentence by 0.0001381.

X
- Definition Total amount of registration fee (amount due after offsets). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 + Details
Name: | ffd_FeeAmt
Namespace Prefix: | ffd_
Data Type: | ffd:nonNegative1TMonetary2ItemType
Balance Type: | na
Period Type: | duration

X
- Definition The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 + Details
Name: | ffd_FeeRate
Namespace Prefix: | ffd_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 + Details
Name: | ffd_OfferingNote
Namespace Prefix: | ffd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ffd_OfferingTable
Namespace Prefix: | ffd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ffd_PrevslyPdFlg
Namespace Prefix: | ffd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ffd_Rule011Flg
Namespace Prefix: | ffd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | ffd_TxValtn
Namespace Prefix: | ffd_
Data Type: | ffd:nonNegative100TMonetary2ItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ffd_OfferingAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |